Publicaciones en las que colabora con Pilar Catalán Rodríguez (93)

2024

  1. Accelerating SARS-CoV-2 genomic surveillance in a routine clinical setting with nanopore sequencing

    International Journal of Medical Microbiology, Vol. 314

  2. Neutralizing antibody levels detected early after mRNA-based vaccination do not predict by themselves subsequent breakthrough infections of SARS-CoV-2

    Frontiers in Immunology, Vol. 15

  3. No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir

    Journal of Medical Virology

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  2. Alternative molecular and genomic strategies to provide a rapid response to alerts concerning the introduction of new emerging SARS-CoV-2 variants: the Omicron alert

    Microbiology Spectrum, Vol. 11, Núm. 5

  3. Cytomegalovirus reactivation in patients diagnosed with severe COVID-19: A point prevalence study in a general hospital

    Revista Espanola de Quimioterapia, Vol. 26, Núm. 1, pp. 45-51

  4. Demographic, clinical and microbiological characteristics of the first 30 human monkeypox confirmed cases attended in a tertiary hospital in Madrid (Spain), during the May-June 2022 international outbreak

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 2, pp. 194-200

  5. Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain

    Emerging infectious diseases, Vol. 29, Núm. 6, pp. 1154-1161

  6. Frequent Emergence of Resistance Mutations Following Complex Intra-Host Genomic Dynamics in SARS-CoV-2 Patients Receiving Sotrovimab

    Antimicrobial agents and chemotherapy, Vol. 67, Núm. 7, pp. e0026623

  7. Longitudinal Whole-Genome Sequence Characterization of a Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.5 Infection in an Immunocompromised Patient Successfully Treated with Sotrovimab 1000 mg

    Clinical Infectious Diseases

  8. Rapid Identification of Relevant Microbial Strains by Identifying Multiple Marker Single Nucleotide Polymorphisms via Amplicon Sequencing: Epidemic Monkeypox Virus as a Proof of Concept

    Microbiology Spectrum, Vol. 11, Núm. 1

  9. Systematic genomic analysis of SARS-CoV-2 co-infections throughout the pandemic and segregation of the strains involved

    Genome medicine, Vol. 15, Núm. 1, pp. 57

  10. Systematic influenza screening in cardiac intensive care units during the influenza season: A prospective study in Spain

    International Journal of Infectious Diseases, Vol. 136, pp. 37-42

2022

  1. Different performance of three point-of-care SARS-CoV-2 antigen detection devices in symptomatic patients and close asymptomatic contacts: a real-life study

    Clinical Microbiology and Infection, Vol. 28, Núm. 6, pp. 865-870

  2. First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 10, pp. 546-549

  3. First importations of SARS-CoV-2 P.1 and P.2 variants from Brazil to Spain and early community transmission

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 5, pp. 262-265

  4. High SARS-CoV-2 viral load in travellers arriving in Spain with a negative COVID-19 test prior to departure

    Journal of travel medicine, Vol. 29, Núm. 3

  5. High incidence of COVID-19 at nursing homes in Madrid, Spain, despite preventive measures

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 3, pp. 288-292

  6. IgG anti-RBD levels during 8-month follow-up post-vaccination with BNT162b2 and mRNA-1273 vaccines in healthcare workers: A one-center study

    Frontiers in Cellular and Infection Microbiology, Vol. 12

  7. Monkeypox in humans: a new outbreak

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 6, pp. 509-518